DOSAGE REGIMEN FOR FINGOLIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS

摘要

S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.